Psychiatry

Back to articles

Quetiapine prescribing decreased after clinicians received Medicare letters

KEY POINT

High-volume primary care prescribers of quetiapine who received letters stating their use of the drug was higher than their peers and was under review by Medicare resulted in less prescribing of the drug. This outcome persisted over 2 years, with no apparent adverse effects on patients, according to results of a trial published in JAMA Psychiatry.